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Abstract .  Vibrio cholerae and Escherichia coli heat la- 
bile toxins (CT and LT) elicit a secretory response from 
intestinal epithelia by binding apical receptors (ganglio- 
side GM1 ) and subsequently activating basolateral effec- 
tors (adenylate cyclase). We have recently proposed 
that signal transduction in polarized cells may require 
transcytosis of toxin-containing membranes (Lencer, 
W. I., G. Strohmeier, S. Moe, S. L. Carlson, C. T. Con- 
stable, and J. L. Madara. 1995. Proc. Natl. Acad. Sci. 
USA. 92:10094-10098). Targeting of CT into this path- 
way depends initially on binding of toxin B subunits to 
GMI at the cell surface. The anatomical compartments 
in which subsequent steps of CT processing occur are 
less clearly defined. However, the enzymatically active 
A subunit of CT contains the ER retention signal 
KDEL (RDEL in LT). Thus if the KDEL motif were 
required for normal CT trafficking, movement of CT 
from the Golgi to ER would be implied. To test this 
idea, recombinant wild-type (wt) and mutant CT and 
LT were prepared. The COOH-terminal KDEL se- 
quence in CT was replaced by seven unrelated amino 
acids: LEDERAS. In LT, a single point mutation re- 
placing leucine with valine in RDEL was made. Wt and 
mutant toxins displayed similar enzymatic activities and 
binding affinities to GM1 immobilized on plastic. Bio- 
logic activity of recombinant toxins was assessed as a 
C1- secretory response elicited from the polarized hu- 
man epithelial cell line T84 using standard electrophys- 
iologic techniques. Mutations in K(R)DEL of both CT 
and LT delayed the time course of toxin-induced C1- 
secretion. At T1/2, dose dependencies for K(R)DEL- 
mutant toxins were increased ~>10-fold. KDEL- 
mutants displayed differentially greater temperature 
sensitivity. In direct concordance with a slower rate of 
signal transduction, KDEL-mutants were trafficked to 
the basolateral membrane more slowly than wt CT (as- 
sessed by selective cell surface biotinylation as transcy- 
tosis of B subunit). Mutation in K(R)DEL had no ef- 
fect on the rate of toxin endocytosis. These data 
provide evidence that CT and LT interact directly with 
endogenous KDEL-receptors and imply that both tox- 
ins may require retrograde movement through Golgi 
cisternae and ER for efficient and maximal biologic ac- 
tivity. 
ETROGRADE transport through Golgi cisternae has 
been shown to occur for soluble and membrane 
proteins of the ER (49) and for certain protein tox- 
ins (6, 55). Targeting of soluble ER and some type II mem- 
brane proteins in this pathway depends on the COOH-ter- 
minal sorting signal Lys-Asp-Glu-Leu (KDEL or HDEL 
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in yeast) (42, 48, 62). Targeting of type I membrane pro- 
teins depends on a short cytoplasmic double lysine motif 
(19, 20, 43). Retrograde transport of shiga toxin from the 
cell surface through Golgi stacks to ER appears to depend 
on the structure of the toxin's cell surface receptor gly- 
cosphingolipid Gb3 (56). Movement of shiga toxin along 
this pathway may be required for toxin action. Likewise, 
the function of Pseudomonas exotoxin A may depend on 
toxin entry into Golgi or ER as evidenced by sensitivity to 
mutation in the toxin's COOH-terminal REDLK se- 
quence and rescue by replacement with KDEL (6). 
The heat labile enterotoxins produced by Vibrio chol- 
erae (cholera toxin, CT 1) and Escherichia coli (heat labile 
1. Abbreviat ions used in this paper: CT, Cholera toxin; Isc, short circuit 
current; LT, heat labile toxin; R, resistance; wt, wild-type. 
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toxin, LT) also contain respectively the KDEL or the 
equally potent sorting signal RDEL at the C-terminus of 
their enzymatically active A subunits (59, 60). CT and LT 
are structurally, immunologically, and functionally homol- 
ogous (reviewed in reference 61). Both toxins act directly 
on intestinal epithelia to elicit massive secretory diarrhea 
by activating cAMP-dependent signal transduction path- 
ways. Both CT and LT are comprised of five identical B 
subunits that bind with high affinity to ganglioside GM1 at 
the cell surface (7, 17, 25), and a single enzymatic A sub- 
unit comprised of two peptides linked by a disulfide bond 
(59, 66). After reduction of the A subunit, the enzymati- 
cally active At-peptide (~22 kD) acts inside the cell to 
activate adenylate cyclase by catalyzing the ADP-ribo- 
sylation of the heterotrimeric GTPase Gsct (5, 39, 40). 
The A2-peptide (~5 kD) contains the COOH-terminal 
K(R)DEL motif that protrudes unhindered below the 
plane formed by the pentameric B subunit on the side 
which binds GMI at the cell surface (36, 59, 60). 
The presence of K(R)DEL at such a site on both CT 
and LT raises the distinct possibility that both toxins re- 
quire direct interactions with endogenous KDEL-recep- 
tors for biologic activity (50). The KDEL-receptor is a 
seven-transmembrane domain protein localized predomi- 
nantly to the intermediate compartment and Golgi cister- 
nae with a graded distribution from cis to trans (16, 63). 
The KDEL-receptor mediates retrograde transport of 
KDEL-containing proteins from multiple sites within 
Golgi cisternae including trans-Golgi (8, 20, 31, 37, 52). 
The process by which CT elicits a response in polarized 
and nonpolarized cells takes 20-40 min (termed the "lag" 
phase) (11, 28) and involves movement of CT through 
multiple intracellular compartments. Binding of CT to the 
cell surface is followed by endocytosis and subsequent 
transport of toxin containing membranes to a functionally 
defined intracellular compartment(s) where reduction and 
membrane translocation of the A subunit occurs (27, 45). 
The anatomical compartment of A subunit translocation, 
however, remains unknown though available evidence 
suggests this event may occur in Golgi cisternae. For ex- 
ample, CT-labeled horseradish peroxidase or gold parti- 
cles have been shown to move from the cell surface via en- 
dosomes to trans-Golgi (23), and recently, a small fraction 
of internalized CT B subunit has been localized within cis 
elements of Golgi cisternae (56). These data provide direct 
evidence that CT can move retrograde in the secretory 
pathway. Neither study, however, provides evidence that 
transit through Golgi is physiologically relevant to the cel- 
lular response. 
The lag phase ends with activation of adenylate cyclase 
by toxin-catalyzed ADP-ribosylation of Gsa. Activation of 
adenylate cyclase occurs by movement of the reduced and 
translocated Al-peptide (or possibly another messenger) 
back to the plasma membrane. The events that follow re- 
duction (and presumably translocation [24]) of the A sub- 
unit are not necessarily diffusion limited. In polarized T84 
cells, for example, signal transduction by the reduced 
Al-peptide is completely inhibited late in the lag phase by 
lowering incubation temperatures from 37 to 15°C (28). 
These and other data (13, 14, 69) suggest that the At-pep- 
tide may not break free of the membrane after transloca- 
tion. We have recently found that after translocation the 
Arpept ide may not dissociate from membrane vesicles 
containing the B subunit. Both subunits may move to- 
gether via vesicular carriers from the site of translocation 
to adenylate cyclase on the basolateral membrane (29). 
Our aim in the present study was to define intermediary 
compartments through which CT and LT must physiologi- 
cally traffic to elicit a cellular response. We examined 
whether the COOH-terminal K(R)DEL motif of the 
A2-peptide may play a role in toxin action. If K(R)DEL 
were required for normal CT or LT signal transduction, 
retrograde movement of CT/LT from Golgi to ER would 
be implied. Recombinant wild-type (wt) and mutant CT 
and LT were prepared. The COOH-terminal KDEL se- 
quence in CT was replaced by seven unrelated amino ac- 
ids: LEDERAS. In LT, a single point mutation replacing 
leucine with valine was made. Toxin action was examined 
in the human intestinal cell line T84, a polarized cell model 
of intestinal epithelia and the natural target of CT in na- 
ture. T84 cells grown on permeable supports form conflu- 
ent monolayers of columnar epithelia that exhibit high 
transepithelial resistance, polarized apical and basolateral 
membranes, and a cAMP-regulated C1- secretory pathway 
analogous to that found in intact intestine (1). Activation 
of adenylate cyclase in T84 cells by intoxication with CT or 
LT elicits a strong CI- secretory response that can be de- 
tected using standard electrophysiologic techniques. Our 
data provide strong evidence that CT and LT interact di- 
rectly with endogenous KDEL-receptors and imply that 
both toxins may require retrograde movement through 
Golgi cisternae and ER for efficient and maximal biologic 
activity. 
Materials and Methods 
Materials 
Cholera toxin (CT) was obtained from Calbiochem Novabiochem (San 
Diego, CA). Sulfo-NHS-biotin, sulfo-NHS-acetate, and protein-A-Sepharose 
were purchased from Pierce (Rockford, IL). All other reagents were from 
Sigma Chemical Co. (St. Louis, MO) unless otherwise stated. Hanks bal- 
anced salt solution (HBSS, containing in g/L 0.185 CaCI2, 0.098 MgSO4, 
0.4 KCI, 0.06 KH2PO 4, 8 NaC1, 0.048 Na2HPO4, 1 glucose, to which was 
added 10 mM Hepes, pH 7.4) was used for all assays unless otherwise 
stated. 
Cell Culture 
T84 cells obtained from ATCC were cultured and passaged as previously 
described (9) in equal parts of DME (1 g/L D-glucose) and Ham's  F-12 
Nutrient mixture, supplemented with 5% newborn calf serum, 15 mM 
Hepes, 14 mM NaHCO3, 40 mg/L penicillin, 8 mg/L ampicillin, and 0.90 
mg/L streptomycin. Cells were seeded at confluent density onto 0.33- or 
5-cm 2 Transwell inserts (Costar Corp., Cambridge, MA) coated with a di- 
lute collagen solution as previously described (33). Transepithelial resis- 
tances attained stable levels (>1,000 ohms cm 2) after 7 d. The develop- 
ment of high transepithelial resistance correlated with the formation of 
confluent monolayers with well-developed tight junctions as assessed by 
morphological analysis (32), and with the ability of monolayers to secrete 
CI-. Cells from passages 71-84 were utilized for these experiments. 
Preparation of Recombinant Wild-type and Mutant 
CT and LT 
Mutagenesis of the COOH-terminal K(R)DEL Sequence. The LT-RDEL se- 
quence was mutated in plasmid pTRH29, a derivative of the plasmid vec- 
tor pBluescript IIKS+, that contains the genes for the A and B subunits 
of E. coli labile toxin (70). Mutagenesis of Leu 24° to Val at the COOH ter- 
minus of the A subunit was performed with an in vitro oligonucleotide- 
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directed mutagenesis kit (Amersham International, Arlington Heights, 
IL) using single-stranded pTRH29 as a template and a synthetic oligonu- 
cleotide (5'-TATTCAT__ACTTCATCC-3', from the Microanalytical Facil- 
ity, IAPGR, Cambridge Research Station, UK) as the mutagenic primer. 
The correct Leu to Val substitution was confirmed by dideoxy sequencing 
using Sequenase I1 (United States Biochemical Corp., Cleveland, OH) 
and the resultant pIasmid designated pTRH73. The clone producing the 
CT variant with LEDERAS substituted for KDEL at the COOH termi- 
nus of the A subunit was constructed in two steps. First the Lys 237 codon 
A A G  (italicized letters in the sequence GAATI'AAG) in pMGJ60 was 
changed by oligonucleotide-directed mutagenesis to CAG, thereby creat- 
ing the EcoR1 restriction site GAAT T C  in the resulting plasmid pMGJ67 
(22). Next, a PvuII-EcoRI fragment of pMGJ67 that encodes the IPTG- 
inducible, truncated ctxA gene was subcloned into PvuII-EcoRI cut 
pBR322 to generate pMGJ117, and the predicted fusion joint was con- 
firmed by dideoxy sequencing. Fusion of ctxA to vector-derived se- 
quences in pMGJl l7  substitutes LEDERAS for KDEL at the COOH ter- 
minus of the A subunit of CT, in a manner equivalent to the LEDERAS 
variant of LT constructed by Sanchez et al. (54). To produce holotoxin 
with the LEDERAS variant of CT-A, pMGJ117 was transformed into E. 
coli TX1 (Stratagene Inc., La Jolla, CA) containing pMGJ85, a compati- 
ble plasmid clone that expresses ctxB from the IPTG-inducible promoter 
of pK184 (21). 
Preparation of Periplasmic Extracts Containing Recombinant Wild-type and 
Mutant CTand LT. E. coli XL1-Blue (fecAl lac- endA1 gyrA96 thi hsdR17 
supE44 relA1 IF' proAB lacIq lacZAM15 Tnl0]) (4) or TX1 harboring 
plasmids encoding wild-type or mutant CT or LT were inoculated from 
stocks into 200 ml Luria-Bertani medium (L-broth) (53) supplemented 
with 200 ~g/ml ampicillin and 10 p.g/ml tetracycline. The cells were grown 
at 37°C on a rotary shaker. When the culture had reached an optical den- 
sity of 0.2 (600 nm), isopropyl-l-thio-13-o-galactopyranoside (0.5 mM fi- 
nal) was added and the cells cultured for an additional 2 h. The cells were 
then collected by centrifugation (6,000 rpm, 4°C for 15 rain) and washed in 
4 ml of ice-cold PBS (NaC1 140 raM, Na2HPO3/NaH2PO3 10 mM, pH 7.2) 
and then resuspended in 8 ml of ice-cold 0.3 M sucrose, 0.1 M Na2HPO3/ 
NaH2PO3, pH 7.6. EDTA (5 mM) and lysozyme (10 p.g/ml) were added 
and the cells kept on ice for an additional 15 min with occasional agitation. 
The treated cells were centrifuged (12,000 rpm at 4°C for 5 min) and the 
supernatant containing the periplasmic extract removed, dialyzed over- 
night against two changes of HBSS (1:1,000 vol/vol), separated into 20-50- 
~l aliquots, flash frozen, and stored at -80°C until required. 
Electrophysiology 
For electrophysiological studies, confluent monolayers on Transwell in- 
serts were transferred to HBSS and preincubated with apical CT at 4°C 
for 30 rain before shifting to fresh HBSS at 37°C. Measurements of short 
circuit current (Isc) and resistance (R) were performed with 0.33-cm 2 
monolayers as previously described (9, 28, 33). Serosal and mucosal reser- 
voirs were interfaced with calomel and Ag-AgC1 electrodes via 5% agar 
bridges made with Ringers buffer (114 mM NaCl, 5 mM KCI, 1.65 mM 
Na2HPO4, 0.3 mM NaH2PO4, 25 mM NaHCO3, 1.1 mM MgSO4, 1.25 mM 
CaCl2). Measurements of resistance were made using a dual voltage/cur- 
rent clamp device (University of Iowa, Iowa City, Iowa) and 25-~tA cur- 
rent pulses. Isc was calculated using Ohm's  law. 
Selective Cell Surface Biotinylation 
Methods described by Sargiacomo et al. (1989) and Le Bivic et al. (1990) 
were modified for use in the Tg4 cell system as described (29). 
GM1 Binding and ELISA 
Fluorescein-labeled CT (CT-fluorescein) (28) was used to define binding 
of recombinant toxins to GM1 immobilized on plastic micro-titre plates as 
previously described (30). Dynatec microfluor 96-well black microtitre 
plates were coated with type III gangliosides (20 Ixg/ml; Sigma Chemical 
Co.) in 60 mM sodium carbonate, pH 9.9, and incubated at 37°C for 36-48 h 
as previously described (34). After washing in PBS (140 mM NaCI, 10 mM 
Na2HPO3/NaH2PO3, pH 7.4) the plates were blocked in PBS containing 
5% BSA. CT-fluorescein (3.1 nM in PBS containing 2.5% BSA, pH 7.4) 
was applied to each well with increasing concentrations (0.05-50 nM) of 
recombinant wt and mutant toxins or buffer alone, incubated for 30 min at 
37°C, washed with PBS, and fluorescence quantified in a fluorescence con- 
centration analyzer (Pandex Fluorescence Plate Reader; Baxter, McGraw 
Park, IL). 
To assay toxin concentrations an EL|SA-based assay was used. Peri- 
plasmic extracts containing recombinant toxins were applied to 96-well 
microtitre plates coated with ganglioside GM1 as previously described (34). 
After 30 min at 37°C, the plates were washed with PBS, pH 7.4, and the 
presence of CT or LT bound to GM1 was assayed by routine ELISA using 
rabbit polyclonal antiserum raised against either CT-A subunit or CT B 
subunit (27, 29). Toxin concentrations were confirmed by SDS-PAGE and 
Western blot. 
Toxin-catalyzed ADP-Ribosylation of Agmatine 
NAD:agmatine ADP-ribosyltransferase activity was assayed as described 
by Tsai (64) with minor modifications. Recombinant wt or K(R)DEL- 
mutant toxins (~200 nM final) were incubated at 30°C for 60 rain with 15 
mM agmatine, 100 I~M nicotinamide adenine dinucleotide (NAD, con- 
taining 0.02 ~Ci [carbonyl-14C]NAD), 1 mM GTP, 50 mM KHzPO4, 4 mM 
MgCI2, 20 mM dithiothreitol, 0.3 mg/ml ovalbumin, 2 mg/ml cardiolipin, 
200 I~M cibachrome blue, and 20 Ixl crude guinea pig brain cytosol (as a 
source of ADP-ribosylating factor) in a final volume of 100 p.l. Reactions 
were terminated with the addition of 1 ml 1% SDS in water and applied to 
AG l-X2 (Bio-Rad Labs., Richmond, CA) 0.25 × 2-cm columns. The col- 
umns were washed with 4 ml of distilled water and eluates containing hy- 
drolyzed [carbonyl-14C]nicotinamide were assayed by scintillation count- 
ing. Recombinant toxins were first activated by incubation with 30 mM 
dithiothreitol for 60 min at 30°C. Three point calibration was provided by 
incubation with dithiothreitol activated purified CT (1 or 0.01 ~M; Calbio- 
chem Novabiochem) or buffer alone. The assay was linear within these 
toxin concentrations as assessed by formal dose responses. 
Guinea pig brain was homogenized (15 strokes in tight fitting Dounce) 
in 0.34 M sucrose, 0.1 mM MgCI2, 1 mM EDTA, 10 mM Hepes, pH 7.4, 
containing 1.25 mM PMSF and 0.5 ~l/ml chymostatin. Cytosol was pre- 
pared by differential centrifugation and defined as the supernatant of a 
100,000 g spin for 60 min. 
SDS-PAGE, Immunoprecipitation, and 
Western Blotting 
Recombinant toxins were analyzed on 10-20% polyacrylamide gradient 
gels under reducing conditions (unless otherwise indicated for A subunit) 
and either Coomassie stained or transferred to 0.25-1J.m nitrocellulose 
membranes. Rabbit antisera raised against CT-A and CT-B subunits were 
used as described (29) and diluted 1:200 for immunoprecipitations and 1: 
1,000 for western blotting. Pre-stained molecular mass markers (Bio-Rad 
Labs.) contained: lysozyme (18.5 kD), soybean trypsin inhibitor (27.5 kD), 
carbonic anhydrase (32.5 kD), ovalbnmin (49.5 kD), bovine serum albu- 
min (g0 kD), and phosphorylase B (106 kD). 
Endocytosis 
Methods described by Orlandi and Fishman were modified for use in the 
T84 cell system (44). Recombinant toxins (20 nM) were incubated with 
confluent monolayers of T84 cells grown on plastic 96-well plates at 4°C 
for 20 min and then shifted to 37°C or kept at 4°C. At the indicated times, 
monolayers were returned to 4°C and washed. Toxin remaining at the cell 
surface was measured by immunoreactivity to anti-serum raised against 
CT B subunit (1:200 dilution) (29), secondary incubation with horseradish 
peroxidase-labeled anti-IgG, and development with 2, 2'-azino-bis (3-eth- 
ylbenzthiazoline)-6-sulfonic acid. Assays were performed in triplicate or 
quadruplicate and reproduced four times. Two point calibrations for each 
experiment were provided by incubation at 4°C (positive control) and in- 
cubations without CT (negative control, ~30% of maximal signal). Means 
--- SE are reported. 
Statistics 
Data were analyzed using Statview 512+ software (Brainpower, Inc., Cala- 
basas, CA). 
Results 
Preparation of Recombinant CT and LT 
Mutations were engineered into the COOH-terminal 
K(R)DEL sequence of the A subunit of V. cholerae and E. 
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coli heat-labile enterotoxins. In CT, the COOH-terminal 
KDEL sequence was replaced by the unrelated seven- 
amino acid sequence: Leucine-Glutamic acid-Aspartic acid- 
Glutamic acid-Arginine-Alanine-Serine (Fig. 1). In LT, 
the COOH-terminal RDEL sequence was altered by a sin- 
gle point mutation replacing leucine with valine (Fig. 1 B). 
Both removal of KDEL and substitution of valine for leu- 
cine have been shown to inhibit post-ER retrieval of 
K(R)DEL-containing proteins in other eucaryotic systems 
(47, 48, 71). Recombinant wild-type and mutant CT and 
LT were expressed from plasmid vectors in E. coli XL1- 
Blue, followed by extraction of periplasmic proteins (con- 
taining the recombinant toxins) as described in Materials 
and Methods. Toxin concentrations were determined by 
GM~-ELISA against both CT A and pentameric B sub- 
units. Further analysis by SDS-PAGE and Western blot 
showed that A and B subunits of both mutant and wild- 
type toxins were present in known concentrations. As as- 
sessed by GMI-ELISA, A and pentameric B subunits were 
present in ~1:1 ratio indicating that all functional recom- 
binant B subunits were fully assembled with A subunits. 
Further functional analysis of toxin assembly by competi- 
tive inhibition with recombinant B subunit confirmed 
these results (see below). 
Mutation in COOH-terminal KDEL Does Not 
Affect Toxin Binding or ADP-ribosyl-transferase 
Activity In Vitro 
Toxin binding to GMl immobilized on plastic was exam- 
ined in vitro to determine whether mutation in K(R)DEL 
may affect indirectly the ability of the toxin B subunits to 
associate with cell membranes. Fluorescein-labeled CT 
was utilized to generate binding isotherms for wt and mu- 
tant CT and LT. Fig. 2 shows that both the RDEL- (A) 
and KDEL-mutant  (B) bound to GM~ with apparent affini- 
ties that were nearly identical to that of wt LT and wt CT 
(Ka -~6 nM). Competition with increasing concentrations 
of heat denatured CT had no effect on CT-fluorescein 
binding, indicating that binding was specific. 
Enzymatic activities of recombinant toxins (not pro- 
teolytically nicked in the exposed loop between the A1 and 
A2-peptide) were assessed by in vitro ADP-ribosylation of 
agmatine (64) (Fig. 3). These data show that wt and 
KDEL-mutant  CT (200 nM) displayed nearly identical 
ADP-ribosyltransferase activities in vitro (1.6 - 0.08 vs. 
1.8 _+ 0.02 nmol NAD hydrolyzed/h, mean + SD in tripli- 
cate, representative of two independent experiments). 
Mutation in the COOH-terminal K(R)DEL Sequence 
Impedes the Time Course of  Toxin Action 
Initial experiments with T84 cells showed that mutation in 
the K(R)DEL sequence delayed the onset of toxin- 
induced C1- secretion. At T1/2 (half-maximal secretion: 50 
rain for wt CT and 80 rain for wt LT), secretory responses 
elicited by wild-type toxins were two- to threefold stronger 
than those elicited by corresponding KDEL- (26 + 3 vs. 8 
-+ 2 p~A/cm 2) or RDEL-mutants  (25 _+ 0.7 vs. 13 _+ 1 ~A/ 
cm2; mean _+ SE, n = 6-8). Periplasmic extracts from a 
control E. coli strain XL1-Blue not harboring toxin clones 
were electrically silent. Mutation in K(R)DEL affected 
both the initial lag phase and rate of toxin induced Cl- se- 
cretion (Fig. 4 and Table I). The inhibitory effect on the 
kinetics of toxin action appeared greater in monolayers 
exposed to lower toxin concentrations (Fig. 4, C and D) 
but was otherwise not dose dependent. At T1/2, dose de- 
pendencies for both mutant toxins were increased />10- 
fold (Fig. 5). At high toxin concentrations (100 nM), the 
maximal secretory responses eventually reached were not 
significantly different (Fig. 4, A and B). 
KDEL-mutants were not degraded by intracellular pro- 
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Figure t. Preparation of re- 
combinant wild-type and 
K(R)DEL-mutant toxins. 
Primary structures for wild- 
type and mutant CT (A) and 
LT (B) are shown. Recombi- 
nant toxins were harvested in 
periplasmic extracts and ana- 
lyzed by SDS-PAGE. Coo- 
massie stains A show: peri- 
plasmic extracts containing 
KDEL-mutant CT (lane 1) 
and wt CT (lane 2); and puri- 
fied CT from V. choterae 
(lane 3). Coomassie stains B 
show: purified CT from V. 
cholerae (lane 1); and peri- 
plasmic extracts containing 
RDEL-mutant LT (lane 2) 
and wt LT (lane 3). Western 
blots A show: purified CT 
from V. cholerae (lane 1); 
and periplasmic extracts c o n -  
taining wt CT (lane 2) or KDEL-mutan t  CT (lane 3, the KDEL-mutan t  migrates at a slightly slower rate than wt CT). Anti-sera against 
A subunit  which cross reacts weakly with B subunit was used for western blotting. Western  blots B show: purified CT from V. cholerae 
(lane I);  and periplasmic extracts containing wt LT (lane 2) or RDEL-mutan t  LT (lane 3). Combined anti-sera against A and B sub- 
units were used for western blotting. Both  A and B subunits are indicated. 
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Figure 2. E f f e c t  o f  m u t a t i o n  
in K(R)DEL on toxin bind- 
ing to ganglioside GM1. The 
fluorescent toxin analogue, 
CT-fluorescein, was used as 
tracer as described in Materi- 
als and Methods. Binding 
isotherms for both wt and 
K(R)DEL mutant toxins 
were nearly identical and of 
equally high affinity (Kd ~6 
nM). Representative of two 
independent experiments in 
duplicate. 
cessing faster than wt CT (Fig. 6). Nearly identical amounts 
of A and B subunit were immunoprecipitated from T84 
cells after 15, 60, and 120 min incubations at 37°C. To ex- 
clude the possibility that mutation in K(R)DEL affected 
toxin action indirectly by affecting assembly of A and B 
subunits, recombinant LT-B subunits were applied to T84 
monolayers in competition with K(R)DEL-mutant  or wt 
toxins (Fig. 7). Recombinant LT B subunit displayed 
nearly identical IC50's for inhibition of toxin action (IC50 
= 10 - 4 nM vs. 10 -+ 6 nM, for RDEL-mutant  and wt LT, 
mean + SD, n = 2 in duplicate, upper panel; and IC50 = 11 
_ 1 nM vs. 11 _+ 4 nM for KDEL-mutant  and wt CT, mean 
+ SD, n = 3 in duplicate, lower panel). These data confirm 
that mutation in K(R)DEL had no detectable effect on 
toxin assembly and periplasmic extracts contained little or 
no free B subunit. 
Taken together, these data provide evidence that the 
K(R)DEL motif is not absolutely required for toxin ac- 
tion, but in its absence signal transduction is significantly 
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Figure 3. Effect of mutation 
in KDEL on the enzymatic 
activity of the A subunit of 
CT. ADP-ribosyltransferase 
activity of KDEL-mutant 
and wt CT (0.2 txM, not 
nicked). CT purified from V. 
cholerae (i.e., nicked), at 1 
txM, 0.01 txM, and vehicle 
alone provide three point cal- 
ibration (mean _+ SD, n = 3). 
and LT to mutation in K(R)DEL strongly implies that 
both toxins require functional interaction with endoge- 
nous KDEL-receptors within Golgi cisternae or ER for ef- 
ficient retrograde transport and maximum biologic activity. 
Effect of  Cell Polarity on Signal Transduction 
by KDEL-Mutants 
When applied to basolateral instead of apical reservoirs, 
CT can bind to the cell at a site in close proximity to its tar- 
get enzyme adenylate cyclase. Signal transduction from 
basolateral cell surfaces, however, also requires endocyto- 
sis and subsequent transport of CT through multiple com- 
partments of the central vacuolar network (27, 45). 
To examine whether signal transduction via basolateral 
receptors may also require sorting by K(R)DEL, it was 
necessary to first proteolytically nick (trypsin, 20 lxg/ml) 
the exposed loop between the A1- and A2-peptides (resi- 
dues 187-199) (35). The A subunits of the recombinant 
toxins are not nicked by endogenous proteases in E. coli as 
they are in V. cholerae (Fig. 1, Western blots). This has no 
effect on the time course of toxin action when applied to 
apical cell surfaces in the T84 cell system where both re- 
combinant CT and LT are nicked by a protease(s) at the 
apical cell surface. Nicking, however, appears to be rate 
limiting when toxins are applied to basolateral membranes 
(unpublished data). 
Signal transduction by toxin internalization via basolat- 
eral endosomes was also sensitive to mutation in the 
K(R)DEL sorting signal (Fig. 8). KDEL-mutants  applied 
to either apical (A) or basolateral cell surfaces (B) elicited 
a secretory response more slowly than wild-type CT. Both 
the initial lag phase and rate of toxin induced C1- secre- 
tion were affected (KDEL-mutant  vs. wt CT: lag phase, 53 
+_ 4 vs. 35 __ 7 min; dlsc/dt, 1.4 -+ 1 vs. 2.5 -+ 1.4 ixA/cm2/ 
min; peak Isc, 62 _+ 25 vs. 80 _+ 28 ixA/cm 2, mean _+ SD, n 
= 2 in duplicate). Identical results (qualitatively) were ob- 
tained for wt LT and RDEL-mutants  (data not shown). 
Thus, mutation in K(R)DEL affects a physiologic event in 
the cellular processing of CT that is in common with toxin 
entry through apical or basolateral endosomes. This com- 
mon event displays sensitivity to mutation in the K(R)DEL 
sorting signal and as such represents retrograde traffic of 
CT and LT through proximal components of the secretory 
pathway (compartments shared in polarized cells by the 
apically and basolaterally directed secretory pathway). 
Thus these data fit nicely with the current hypothesis that 
translocation of the A subunit (an event essential for toxin 
action) may occur within Golgi cisternae or ER (50). 
Signal Transduction by KDEL-Mutant CT Displays 
Greater Sensitivity to Temperature 
We examined the temperature dependency of toxin in- 
duced CI- secretion. We reasoned that if the KDEL sort- 
ing signal facilitates a rate-limiting step in toxin action, 
KDEL-mutants  should display greater sensitivity to tem- 
perature. Fig. 9 shows the time course of toxin action for 
KDEL-mutant  (1 nM, open squares) and wild-type CT (1 
nM, filled squares) at three different temperatures (37, 27, 
and 20°C). Lowering temperatures below 37°C reduced 
the rate of toxin induced CI- secretion for both wild-type 
and mutant toxins. Signal transduction by the KDEL- 
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Figure 4. Effect of mutation 
in K(R)DEL on the time 
course of toxin induced C1- 
secretion. The time courses 
of toxin induced C1- secre- 
tion are shown for LT and 
the RDEL-mutant in high 
(100 nM, A) and low doses 
(0.5 nM, C); and for CT and 
the KDEL-mutant in high 
(100 nM, B) and low doses 
(0.5 nM, D). 
mutant, however, was more strongly inhibited by reduced 
temperature. This is most apparent at 20°C (bottom), 
where the ability of the KDEL-mutant to elicit a secretory 
response was completely inhibited, while C1- secretion in- 
duced by wt CT was clearly present. The viability of these 
monolayers was demonstrated by the brisk secretory re- 
sponse elicited by the administration of 3 nM vasoactive 
intestinal peptide to basolateral reservoirs at 480 min 
(marked with * in lower panel). This differential tempera- 
ture dependency was not dependent on toxin concentra- 
tion. Identical results were obtained when wt and mutant 
toxins were applied in fivefold higher concentrations (5 
nM). Table II summarizes the results of seven indepen- 
dent experiments. These data provide additional kinetic 
evidence that specific interactions between CT and endog- 
Table I. Effect of Mutation in K(R)DEL on Toxin Induced 
Cl- Secretion 
Toxin Lag phase dlsc/dt Peak lsc 
min pA/cm2/min I~/cm z 
CT 
KDEL-mutan t  35 + 1" 1.2 -+ 0.06* 45 +- 4 
n = 8  
Wild  type 27 -+ 1 1.8 -+ 0.1 47 -+ 4 
n = 6  
LT 
RDEL-mutan t  53 -+ 2* 0.62 -+ 0.03* 44 + 4 
n = 7  
Wild type 43 +_ 2 0.85 _+ 0.03 52 + 2 
n = 6  
Mean - SE. 
*K(R)DEL-mutant vs. wild-type toxin. 
p = 0.0001 by ANOVA. 
enous KDEL-receptors occur in human intestine and play 
a physiologic role in toxin action. 
Effect of  KDEL-Mutation on Toxin Traffic: 
Endocytosis Is Unaffected but Transcytosis of  the 
KDEL-Mutant Occurs More Slowly Than for 
Wild-type Toxin 
To show directly that mutation in K(R)DEL affects toxin 
trafficking, we examined the time course of endocytosis 
and transcytosis for both wt and KDEL-mutant toxins. 
The reduced efficiency in signal transduction by K(R)DEL- 
mutants may be attributable to an effect on toxin uptake 
by endocytosis. The data show, however, that mutation in 
K(R)DEL had no detectable effect on endocytosis (Fig. 
10). Both wt and K(R)DEL-mutant toxins were internal- 
ized at nearly identical rates with apparent half-times of 
~7.5 min (n = 4, in triplicate or quadruplicate). 
The transcytotic movement of wt and KDEL-mutant 
toxins from apical to basolateral membrane was also ex- 
amined. In polarized intestinal epithelia, CT must trans- 
duce a signal from its apical receptor (GM1) to its basolat- 
eral effector (adenylate cyclase). We have recently found 
that this transcellular signaling may require transcytosis of 
toxin containing membranes (29). Transcytosis of KDEL- 
mutant or wt CT from apical to basolateral membranes 
was assessed directly by selective cell surface biotinylation. 
These experiments were carried out at 27°C to enhance 
the difference in time course between KDEL-mutant and 
wt CT-induced C1- secretion. 
Fig, 11 A shows the representative results of one of 
three independent experiments. The upper panel shows a 
western blot to demonstrate that each lane contains equiv- 
alent amounts of immunoprecipitated CT B subunit. The 
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Figure 5. Effect of mutation 
in K(R)DEL on the dose de- 
pendency of toxin induced 
C1- secretion. Dose depen- 
dency of K(R)DEL-mutant 
(open squares) and wild-type 
(filled squares) LT (A) and 
CT (B). Representative of 
two to three independent ex- 
periments, mean _+ SD for 
duplicate monolayers. 
lower panel shows the avidin blot of monolayers exposed 
to KDEL-mutant or wt CT at 27°C for the indicated times. 
The first and second lanes are positive and negative con- 
trois respectively. Wild-type CT (1 nM) was applied api- 
cally to T84 monolayers and incubated for 160 min at 4°C, 
a temperature that completely inhibits vesicular traffic and 
CT-induced signal transduction (28). The monolayers 
were then biotinylated either at the apical (lane 1) or baso- 
lateral (lane 2) cell surface. The large avidin-peroxidase 
signal (lane 1, bottom) demonstrates that CT B subunit 
can be labeled with biotin while bound to GM1 at the cell 
surface. In the absence of vesicular traffic (at 4°C), how- 
ever, the CT B subunit was not labeled by applying biotin 
to basolateral reservoirs (lane 2). These and supplemental 
data (29) show that CT does not traverse the T84 cell mono- 
layer by diffusion through intercellular tight junctions. 
Lanes 7 and 8 show that in monolayers incubated at 
27°C for 160 min basolaterally applied biotin has now la- 
beled a fraction of the B subunit at the basolateral mem- 
brane indicating that both the KDEL-mutant and wt CT 
had breached the epithelial barrier by transcytosis. The 
fractional component of mutant toxin biotinylated at the 
basolateral membrane, however, was approximately five- 
fold less than wt CT. This corresponds quantitatively to 
the smaller secretory response elicited by the KDEL- 
mutant at this time point (B). Nearly identical results were 
obtained for monolayers incubated at 27°C for 110 min 
(lanes 5 and 6). In contrast, after only 30 min (lanes 3 and 
4), neither the B subunit of KDEL-mutant nor wt CT was 
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Figure 6. Effect of mutation in K(R)DEL on intracellular degra- 
dation. Wild-type (wt) and KDEL-mutant CT were applied to 
apical membranes of T84 cell monolayers and incubated at either 
4°C (lanes I and 5) or 37°C for the indicated times. CT A subunits 
(lanes 1--4) or B subunits (lanes 5-8) were immunoprecipitated 
from total cell extracts (lysed in the presence of 10 mM N-ethyl- 
maleimide) and analyzed by SDS-PAGE and western blot under 
non-reducing conditions. 
labeled by basolaterally applied biotin at a point in the lag 
phase where a secretory response was not yet detected. 
Little or no difference in the amount of B subunit deliv- 
ered to basolateral membranes was detected in monolay- 
ers incubated at 37°C for 90 min (data not shown) or 150 
min (A, lanes 9 and lO, and C). Roughly equivalent amounts 
of mutant and wt toxin were present at the basolateral 
membrane at these time points which correspond (at 
37°C) to nearly maximal secretion for both toxins. 
The amount of wt and KDEL-mutant toxin transcytosed 
were quantified (mean _ SE, n = 3) and displayed super- 
imposed at the appropriate points on the time course of 
CT-induced C1- secretion obtained from monolayers of 
the same passage and studied in parallel (Fig. 11 B). The 
m 
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Figure 7. Effect of competition with recombinant B subunit on 
toxin induced CI- secretion. Competitive inhibition of secretory 
response elicited by K(R)DEL mutant (filled squares) and wt 
(open squares) LT (top) and CT (bottom). Isc's were normalized 
to peak secretory responses for each toxin (35 and 45 ixA/cm 2 for 
RDEL-mutant and LT; 62 ___ 25 and 80 - 28 ixA/cm 2 for KDEL- 
mutant and CT). Representative of two independent experiments 
for duplicate monolayers. 
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Figure 8. Effect of cell polarity on the time course of C1- secre- 
tion elicited by KDEL-mutant and wt CT. Time courses of toxin 
induced secretion are shown for KDEL-mutant and wt CT pro- 
teolytically nicked as described in Materials and Methods. Toxins 
were applied to either apical (top) or basolateral (bottom) cell 
surfaces. Signal transduction by KDEL-mutants were delayed 
from both cell surfaces. Identical results were obtained with 
RDEL-mutant and wt LT (data not shown). Representative of 
two independent experiments for both toxins, mean _ SD for du- 
plicate monolayers. 
appearance of  the B subunit on the basolateral membrane 
coincides temporally and quantitatively with mutant  (open 
squares) and wt CT-induced CI- secretion (filled squares). 
Taken together, these data provide direct evidence that 
mutation in K D E L  affects toxin movement  within a baso- 
laterally directed transcytotic pathway and identify Golgi 
and E R  as intermediary compartments through which CT 
traffics. 
Discussion 
Evidence for Retrograde Transport of  CT and LT into 
Golgi Cisternae and ER 
The results in this paper show that the presence of  a func- 
tional K ( R ) D E L  sequence in CT and LT plays a role in fa- 
cilitating toxin action in human T84 cells and thus implies 
a direct and specific interaction with endogenous KDEL-  
receptors during signal transduction. In the absence of  a 
functional K ( R ) D E L  sequence at the C O O H  terminus of 
the A2-peptide, both mutant  CT and LT elicited a secre- 
tory response more slowly and with higher apparent acti- 
vation energies than their wild-type counterparts. The in- 
teraction between toxin and KDEL-receptor  was specific 
in that a single and conservative point mutation (replacing 
leucine with valine in the R D E L  sequence of LT) affected 
toxin action. These results were not explained by indirect 
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Figure 9. Effect of mutation in KDEL on the temperature de- 
pendency of CT-induced C1- secretion. Time courses of toxin in- 
duced C1- secretion are shown for 1 nM KDEL-mutant (open 
squares) and wt CT (filled squares) at 37, 27, and 20°C. Represen- 
tative of 7 independent experiments, mean _+ SD for duplicate 
monolayers. The * marks the administration of 3 nM vasoactive 
intestinal peptide to basolateral monolayers at 480 rain. 
effects on toxin assembly, toxin binding, resistance to in- 
tracellular degradation, or ADP-ribosyltransferase activ- 
ity. In contrast, we provide direct evidence that K ( R ) D E L  
effected toxin trafficking as assessed by movement  
through the basolaterally directed transcytotic pathway. 
The compartment(s)  affected represent a common struc- 
ture in the apical and basolateral endocytic pathways, as 
mutation in K ( R ) D E L  inhibited signal transduction from 
both cell surfaces. These data provide strong evidence that 
CT and LT may require retrograde movement  through the 
secretory pathway to elicit a maximal secretory response. 
Two lines of  evidence from the available literature sup- 
port  this view. First, CT (conjugated to horseradish perox- 
idase) has been visualized directly within trans-Golgi in 
neuroblastoma cells (23) and recently, purified CT B sub- 
unit (also conjugated to horseradish peroxidase) has been 
visualized within cis-Golgi in A431 epidermoid cells (56). 
These studies show directly that CT can traffic from the 
cell surface to trans-Golgi and retrograde into Golgi cister- 
nae. Movement  into these compartments appears to de- 
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Table II. Effect of Temperature on the Secretory Response Elicited by KDEL-mutant and Wild-type CT 
Lag phase dlsc/dt Peak lsc Ratio*Lag Ratio* dlsc/dt Ratio peak lsc 
min mA/cm2/min mA/cm2 
37°C, n = 7 pairs 
mutant 44 _+ 1 0.59 +-- 0.04 50 +_ 3 
wt 33 -+ 1 1.1 _ 0.1 60 -+ 5 1.333 0.55 0.82 
27°C, n = 7 pairs 
mutant 127 --- 9 0.19 +_ 0.02 25 4- 2 
wt 83 --- 2 0.38 - 0.05 34 4- 3 1.53 0.51 0.74 
20°C, n = 7 pairs 
mutant I>410 + 20 ~<0.012 ___ 0.004 2.5 -+ 0.8 
wt 256 +_ 11 0.48 +_ 0.003 10.5 +- 0.6 ~>1.6 <~0.25 0.24 
Mean _+ SE. 
*KDEL-mutants are significantly more sensitive to temperature than wt CT. 
p = 0.001 by 2-factor ANOVA. 
pend on toxin binding (or clustering) ganglioside GM1 , a s  
purified or recombinant CT B subunit will move into these 
compartments in the absence of sorting signals from the A 
subunit. These data fit nicely with our current findings that 
the K(R)DEL sequence is not absolutely required for 
toxin action, and with our concurrent observations (29) 
that trafficking of CT through a basolaterally directed 
transcytotic pathway also depends primarily on toxin- 
binding (or perhaps clustering) ganglioside GM1. 
Second, the KDEL-receptor, the product of the mam- 
malian ERD2 gene, has now been clearly localized at 
steady-state to Golgi cisternae and intermediate compart- 
ment with small amounts of receptor visualized in ER and 
trans-Golgi (16, 63). KDEL-receptors were not visualized 
at the cell surface or in more distal compartments of the 
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Figure 10. Effect of mutation in K(R)DEL on toxin endocytosis. 
Time course of toxin endocytosis. (Top) wt CT (filled squares), 
KDEL-mutant (filled triangles), and wt CT purified from V. chol- 
erae (open squares). (Bottom) wt LT (filled squares), RDEL- 
mutant (filled triangles). Both wild-type and K(R)DEL-mutant 
toxins display nearly identical rates of internalization with appar- 
ent half-times of ~7.5 rain. 
secretory pathway. Furthermore, the preponderance of 
evidence establishes that KDEL-receptors mediate retro- 
grade transport of other KDEL-containing proteins through 
Golgi cisternae to ER (42, 48, 62). Retrieval and recycling 
to ER occurs from multiple sites in the secretory pathway, 
including trans-Golgi (8, 20, 31, 37, 52). Thus, CT and LT 
would have multiple opportunities to interact with KDEL 
receptors as these toxins move retrograde in the secretory 
pathway via binding (or clustering) ganglioside GM1 (see 
below). 
Components of the apical and basolateral endocytic 
pathways converge in late endosomes (2, 12, 18, 46) and al- 
most certainly in the trans-Golgi, as vesicles exchange con- 
stitutively between these compartments (15 and refer- 
ences therein). Our demonstration, however, that the 
K(R)DEL sorting signal plays a physiologic role in toxin 
action indicates that both CT and LT move beyond the 
late endosome into compartments where interactions be- 
tween toxin and KDEL-receptors may plausibly occur. 
Thus, these studies identify trans-Golgi, Golgi cisternae, 
and possibly ER as intermediary compartments through 
which CT may physiologically traffic to elicit an efficient 
secretory response. Since reduction and translocation of 
the A subunit also represent events that occur in shared 
(or similar) compartments of both the apical and basolat- 
eral endocytic pathways (27), it is tempting to speculate 
that A subunit translocation occurs in ER or possibly 
Golgi cisternae as previously hypothesized (50). If so, 
movement into these compartments would be facilitated 
by direct interaction between toxin and K(R)DEL-recep- 
tors. This prediction fits nicely with our experimental data 
and provides a cogent and biologically plausible explana- 
tion for conservation of the COOH-terminal K(R)DEL 
sorting signal in these two toxins. However, it remains 
possible that mutation in K(R)DEL may also affect mem- 
brane translocation of the A subunit by a mechanism sepa- 
rate from its effect on toxin trafficking. 
Biology o f  Glycosphingolipids and Targeting o f  CTILT 
by Binding or Clustering Ganglioside GM1 
Our current studies, together with those discussed above 
(23, 38, 56), show that both retrograde traffic into the 
secretory pathway and transcytosis across polarized cells 
(29) may plausibly depend on structural features of the 
toxin's endogenous receptor, ganglioside GM1. Glycosphin- 
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Figure 11. Effect of mutation in KDEL on toxin trafficking 
through the transcytotic pathway. T84 cell monolayers grown on 
permeable supports were exposed continuously to 1 nM KDEL- 
mutant (m) or wild-type (wt) CT at the apical cell surface at the 
indicated temperatures and times. Selective cell surface biotinyla- 
tion was performed as described. (A) Top shows western blot of 
immunoprecipitated CT B subunit showing that each lane con- 
tains equivalent amounts of CT B subunit. Bottom shows HRP- 
avidin blot of same experiment. Lane 1, (positive control) 120 
min incubation at 4°C, biotinylation from apical cell surface; lane 
2, (negative control) 120 min incubation at 4°C, biotinylation 
from basolateral cell surface; lanes 3-10 were biotinylated baso- 
laterally; lanes 3 and 4, 30 min incubation at 27°C; lanes 5 and 6, 
110 min incubation at 27°C; lanes 7 and 8, 160 rain incubation at 
27°C; lanes 9 and 10, 160 min incubation at 37°C. (B) Time course 
of KDEL-mutant (open squares) and wt (filled squares) CT- 
induced CI- secretion at 27°C. Relative band optical densities for 
avidin blots of monolayers incubated at 27°C (mean -+ SEM, n = 3) 
are superimposed at the appropriate time points. Signals in lane 8 
(160 min, wt CT) and lane 2 (negative control) for each indepen- 
dent experiment served as two point calibrations. (C) Relative 
band optical densities for avidin blots of monolayers incubated at 
37°C for 150 min. Signals in lanes 9 and 2 served as two point cal- 
ibrations. 
golipids such as ganglioside GM1 a re  expressed exclusively 
on the outer (exo-cytoplasmic) leaflet of cell membranes 
(reviewed in 57, 65, 67, 68). They contribute to the struc- 
ture and function of membrane domains throughout the 
central vacuolar network of eucaryotic cells except per- 
haps ER where they may be present in extremely low con- 
centrations. Transport between distinct intracellular struc- 
tures occurs only by vesicular traffic. Thus, ganglioside 
GM1, which has been shown directly to recycle between the 
cell surface and trans-Golgi in murine NCTC 2071 and rat 
glioma C'6 cells (10), represents an ideal target for toxins 
entering the endocytic and retrograde secretory pathway• 
Targeting of CT and LT into Golgi and ER (though not ef- 
ficient) may simply depend on binding (or clustering) GM1 
via the pentameric B subunit. This would explain our ob- 
servations that the K(R)DEL sorting signal is not abso- 
lutely essential for toxin action. 
Possible Mechanism of  CT Action on 
Polarized Epithelia 
Based on our current understanding, we propose the fol- 
lowing working model of toxin action on polarized epithe- 
lia (Fig. 12). Binding of CT or LT to ganglioside GM1 at the 
apical cell surface is sufficient for targeting these toxins to 
all intracellular compartments necessary for signal trans- 
duction. In the absence of any other targeting information, 
however, retrograde movement of CT or LT through the 
endocytic system to more proximal compartments of the 
secretory pathway is not efficient. Interaction with endog- 
enous KDEL-receptors shifts the steady state distribution 
of the CT-GM1 complex towards Golgi cisternae and ER 
where reduction and translocation of the A subunit may 
occur. If after translocation the Al-peptide breaks free of 
the membrane, activation of adenylate cyclase on the ba- 
solateral membrane may then occur by diffusion through 
the cytosol. Available data indicate, however, that the A l- 
peptide may not dissociate from the membrane after 
translocation (28, 69), and that signal transduction may de- 
pend instead on movement of the CT-GM1 complex back 
out the secretory pathway (via anterograde transport) 
within basolaterally targeted vesicles (29). Escape of toxin 
from the KDEL-recycling pathway into anterograde trans- 
port vesicles may occur as a result of saturation of KDEL- 
receptors (by incoming toxin) or by sequestration of the 
K(R)DEL motif after translocation of the A subunit. Fu- 
sion of toxin-containing vesicles with the basolateral mem- 
brane delivers the Al-peptide to a site where the toxin can 
now catalyze the ADP-ribosylation of Gsc~. Thus, direct 
interaction with endogenous KDEL-receptors facilitates 
toxin entry into Golgi cisternae and ER where reduction 
and translocation of the A subunit may occur and where 
the toxin may now transfer from apically recycling to baso- 
laterally targeted vesicles (Fig. 12). Both maximal toxin 
action and efficient transcytosis then depends on traffick- 
ing through these proximal components of the secretory 
pathway. 
Though transcytosis of toxin-containing membranes from 
apical to basolateral cell surface appears to be required for 
biologic activity, transcytosis of toxin subunits by itself will 
not lead to signal transduction (29). Our current and previ- 
ous studies show that CT must traffic through multiple in- 
tracellular compartments to elicit a C1- secretory response. 
Here we provide evidence that identifies trans-Golgi, Golgi 
cisternae, and possibly ER as intermediary compartments 
through which CT may traffic. Available data indicate that 
this indirect route across T84 cells may be more complex 
than that taken by the apically directed polymeric immu- 
noglobulin receptor (41) or by basolateraUy targeted VSG 
proteins artificially inserted into apical membranes of 
MDCK cells (51). As such, we introduce the term "indirect 
transcytosis" to describe this process. 
We can now tentatively assign anatomic identities to phys- 
iologic compartments previously defined only by functional 
criteria. For example, brefeldin A inhibits completely 
CT-induced signal transduction from both the apical and 
basolateral cell surface. Brefeldin A scrambles protein tar- 
geting and diverts the movement of CT away from a com- 
partment necessary for reduction and translocation of the 
A subunit (27). The brefeldin block occurs early in the lag 
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Figure 12. Proposed model of toxin action on polarized epithelia. 
(Left) Depicts transport steps functionally defined in earlier stud- 
ies. (Right, 1). Toxin enters the cell by binding GMa at the apical 
cell surface. The bulk of the CT-GM1 complex recycles to the api- 
cal cell surface through early and late apical endosomes (shaded 
structures). (2) The COOH-terminal K(R)DEL sorting signal on 
the A subunit facilitates retrograde movement of the CT-GM1 
complex through Golgi cisternae to ER. (3) Reduction and trans- 
location of the A subunit may occur in Golgi cisternae or ER and 
the CT-GM1 complex is sorted (or transferred) from apically recy- 
cling to basolaterally targeted membrane structures. (4) Trans- 
port to the basolateral membrane occurs by anterograde vesicu- 
lar traffic back out the secretory pathway. (5) Fusion of 
basolaterally targeted vesicles carrying the CT-GM1 complex de- 
livers the translocated A subunit to a site near the Gs/adenylate 
cyclase complex on the basolateral membrane. Arrows are scaled 
to depict the steady state distribution of glycosphingolipids within 
the central vacuolar network. AE, apical endosome; TGN, trans- 
Golgi network and Golgi cisternae, ER, endoplasmic reticulum, 
BE, basolateral endosome; AC, adenylate cyclase; Gas, hetero- 
trimeric GTPase Gs. 
phase. Based on our current studies, we propose that 
brefeldin A may inhibit toxin action by inhibiting retro- 
grade transport into trans-Golgi or Golgi cisternae. Either 
of these sites would be consistent with known effects of 
brefeldin A on membrane traffic in both polarized and 
nonpolarized cells (26). 
Signal transduction from the apical membrane of polar- 
ized cells also depends on movement of CT through a sep- 
arate temperature-sensitive step (27, 28). This occurs late 
in the lag phase after the A subunit has been reduced and 
presumably translocated. This temperature-sensitive step 
is not apparent when CT is applied to basolateral cell sur- 
faces, and represents a step(s) uniquely required for signal 
transduction from apical membranes. We propose that this 
late lag phase temperature-sensitive step represents sort- 
ing (or transfer) of toxin from apically derived to basolat- 
erally targeted membrane structures (i.e., membrane mi- 
crodomains). This must occur within Golgi cisternae or 
ER as mutation in K(R)DEL has a clear effect on transcy- 
tosis of CT. In contrast, CT internalized from basolateral 
membranes of the same cells does not display such a dra- 
matic sensitivity to temperature, as signal transduction 
from the basolateral cell surface does not require move- 
ment to the contralateral apical membrane. After arrival 
within Golgi cisternae or ER, the CT-GM1 complex inter- 
nalized from the basolateral cell surface can move retro- 
grade into the secretory pathway and back out again to 
adenylate cyclase on the basolateral membrane by remain- 
ing associated with membrane receptors derived from 
(and presumably targeted to) the basolateral membrane. 
In summary, these studies identify Golgi cisternae and 
ER as intermediary compartments through which CT may 
traffic to elicit an efficient and maximal physiologic re- 
sponse. The unique lipid and protein structure of these 
compartments (3) may provide a thermodynamically or ki- 
netically favorable environment for translocation of the A 
subunit. The COOH-terminal K(R)DEL sorting signal fa- 
cilitates toxin entry into the secretory pathway, but move- 
ment into Golgi cisternae and possibly even ER will occur 
(though not efficiently) in the absence of the K(R)DEL- 
sorting signal after toxin binding (or clustering) ganglio- 
side GM1. Thus CT, as a paradigm for vesicular transport, 
provides an example where protein targeting (and ulti- 
mately the pathogenesis of cholera in humans) depends on 
the combined effects of protein and lipid structure in small 
membrane microdomains (58, 68). 
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Note Added in Proof. After our manuscript was submitted, the following 
paper was published: Cieplak, W., Jr., R. J., Messer, M. E. Konkel, and 
C. C. R. Grant. 1995. Mol. Microbiol. 16:789-800. They also constructed 
and characterized an RDEV mutant of LT, but unlike the results in our 
study, concluded that K(R)DEL was not important for toxin trafficking. 
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